GlassScriptPhysician profile
Joyce A Bonitz
NPI 1922242247
$4,288.55
in general payments reported to CMS, 2019-2025
27 companies · $894 in 2025
The $894 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $335 · 2021: $639 · 2022: $703 · 2023: $922 · 2024: $575 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,390.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,196.48 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $260.23 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbott Laboratories | $176.77 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Csl Behring | $173.91 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $154.86 | 2021 | |
| Davol INC. | $126.67 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $126.34 | 2021-2023 | Andexxa |
| Baudax Bio INC. | $125.00 | 2021 | |
| Portola Pharmaceuticals, LLC | $109.50 | 2019-2020 | |
| Sanara Medtech INC. | $109.31 | 2025 | Biasurge |
| Acell, INC. | $103.47 | 2020 | |
| Becton, Dickinson and Company | $66.86 | 2020-2025 | |
| Teleflex LLC | $63.16 | 2024 | Arrow |
| Innocoll Pharmaceuticals Limited | $59.22 | 2022 | |
| Ucb, INC. | $54.02 | 2021-2024 | Briviact |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $53.32 | 2025 | Restrata Wound Matrix |
| Chiesi USA, INC. | $52.60 | 2025 | Cleviprex |
| Baxter Healthcare | $46.84 | 2021 | |
| Smith+Nephew, INC. | $43.77 | 2024-2025 | Pico 14 |
| Kerecis Limited | $37.95 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Convatec INC. | $36.89 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $35.68 | 2023 | |
| Humacyte Global, INC. | $19.25 | 2025 | Symvess |
| Polarityte, INC. | $17.38 | 2020 | |
| Boston Scientific Corporation | $14.05 | 2022 | |
| Janssen Biotech, INC. | $13.61 | 2023 | Erleada |
| Astellas Pharma US INC | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Bonitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.